Search Results - "Besson NR"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Lymphatic egress recycles tumor-experienced effector CD8 T cells to sustain immune surveillance.

    Authors: Delclaux I Ventre KS Besson NR et al.

    Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 May 05. Date of Electronic Publication: 2026 May 05.

    Publication Type: Journal Article; Preprint

    Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

    Save to List
  2. 2

    IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma.

    Authors: Karakousi T Cristaldi V Lopes de Oliveira ML et al.

    Source: Cancer cell [Cancer Cell] 2026 Apr 13; Vol. 44 (4), pp. 792-808.e9. Date of Electronic Publication: 2026 Jan 22.

    Publication Type: Journal Article

    Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

    Save to List
  3. 3

    A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma.

    Authors: Zhao W Nguyen TT Bhagwat A et al.

    Source: Nature cancer [Nat Cancer] 2025 Nov; Vol. 6 (11), pp. 1857-1879. Date of Electronic Publication: 2025 Oct 07.

    Publication Type: Journal Article

    Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

    Save to List
  4. 4

    Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial.

    Authors: Sehgal K Pappa T Shin KY et al.

    Source: JAMA oncology [JAMA Oncol] 2024 Dec 01; Vol. 10 (12), pp. 1663-1671.

    Publication Type: Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

    Save to List
  5. 5

    A cellular and spatial atlas of TP53 -associated tissue remodeling in lung adenocarcinoma.

    Authors: Zhao W Kepecs B Mahadevan NR et al.

    Source: BioRxiv : the preprint server for biology [bioRxiv] 2024 Feb 14. Date of Electronic Publication: 2024 Feb 14.

    Publication Type: Journal Article; Preprint

    Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

    Save to List
  6. 6

    Intertumoral lineage diversity and immunosuppressive transcriptional programs in well-differentiated gastroenteropancreatic neuroendocrine tumors.

    Authors: Hoffman SE Dowrey TW Villacorta Martin C et al.

    Source: Science advances [Sci Adv] 2023 Sep 29; Vol. 9 (39), pp. eadd9668. Date of Electronic Publication: 2023 Sep 27.

    Publication Type: Journal Article

    Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

    Save to List

Search Tools: